Literature DB >> 22159705

[First line therapy for local advanced or metastasized urothelial carcinoma: randomized double-blind phase II study to compare gemcitabin and cisplatin in combination with OGX-427 or placebo for advanced transitional cell carcinoma of the bladder (OGX-427 - AB 39/11 of the Working Group Urological Oncology)].

H Rexer1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22159705     DOI: 10.1007/s00120-011-2768-3

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


× No keyword cloud information.
  2 in total

Review 1.  Targeted therapies in urothelial carcinoma.

Authors:  Monalisa Ghosh; Sam J Brancato; Piyush K Agarwal; Andrea B Apolo
Journal:  Curr Opin Oncol       Date:  2014-05       Impact factor: 3.645

2.  [Abstracts at congresses of the German Society of Urology. Trends and quality].

Authors:  J von Hardenberg; T Worst; C Weiß; M S Michel
Journal:  Urologe A       Date:  2013-09       Impact factor: 0.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.